Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04425642Completed
Randomised, open-label trial of long-chain triglyceride lipid emulsion in hematologic malignancy (3 arms), sponsored by First Saint Petersburg State Medical University. Primary endpoint: Number of patients with low tolerability of different parenteral nutrition schemes at 60 days. Started Feb 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04425642.